These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 21781153

  • 1. Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project.
    Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S.
    Diabet Med; 2012 Feb; 29(2):207-11. PubMed ID: 21781153
    [Abstract] [Full Text] [Related]

  • 2. Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: one-year follow-up of the FIN-D2D project.
    Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Niskanen L, Puolijoki H, Vanhala M, Uusitupa M, Keinänen-Kiukaanniemi S, FIN-D2D Study Group.
    Scand J Public Health; 2011 Aug; 39(6):561-70. PubMed ID: 21622677
    [Abstract] [Full Text] [Related]

  • 3. Participation, socioeconomic status and group or individual counselling intervention in individuals at high risk for type 2 diabetes: one-year follow-up study of the FIN-D2D-project.
    Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Niskanen L, Saltevo J, Korpi-Hyövälti E, Uusitupa M, Tuomilehto J, Keinänen-Kiukaanniemi S.
    Prim Care Diabetes; 2012 Dec; 6(4):277-83. PubMed ID: 22868007
    [Abstract] [Full Text] [Related]

  • 4. Do depressive symptoms have an impact on the effectiveness of lifestyle counseling in prevention of type 2 diabetes? One-year follow-up of FIN-D2D.
    Rautio N, Jokelainen J, Oksa H, Saaristo T, Moilanen L, Vanhala M, Peltonen M, Korpi-Hyövälti E, Tuomilehto J, Uusitupa M, Timonen M, Keinänen-Kiukaanniemi S.
    Prim Care Diabetes; 2014 Apr; 8(1):43-7. PubMed ID: 24238822
    [Abstract] [Full Text] [Related]

  • 5. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T, Moilanen L, Jokelainen J, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S.
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [Abstract] [Full Text] [Related]

  • 6. Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.
    Rautio N, Jokelainen J, Saaristo T, Oksa H, Keinänen-Kiukaanniemi S, FIN-D2D Writing Group, Peltonen M, Vanhala M, Korpi-Hyövälti E, Moilanen L, Saltevo J, Niskanen L, Tuomilehto J, Uusitupa M.
    J Prim Care Community Health; 2013 Jan; 4(1):59-66. PubMed ID: 23799691
    [Abstract] [Full Text] [Related]

  • 7. Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men.
    Strandberg TE, Salomaa V.
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):239-46. PubMed ID: 11213532
    [Abstract] [Full Text] [Related]

  • 8. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community.
    Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, Mirmiran P, Azizi F.
    Am J Prev Med; 2010 Jun; 38(6):628-636.e1. PubMed ID: 20494239
    [Abstract] [Full Text] [Related]

  • 9. Occupational health care identifies risk for type 2 diabetes and cardiovascular disease.
    Viitasalo K, Lindström J, Hemiö K, Puttonen S, Koho A, Härmä M, Peltonen M.
    Prim Care Diabetes; 2012 Jul; 6(2):95-102. PubMed ID: 22306176
    [Abstract] [Full Text] [Related]

  • 10. [Effect of age on glucose tolerance and cardiovascular risk factors--results of the Diabetes Infobus tour 1998/99 ].
    Fasching P.
    Acta Med Austriaca Suppl; 2002 Jul; 56():17-22. PubMed ID: 12436708
    [Abstract] [Full Text] [Related]

  • 11. Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.
    Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, Ilvesmäki V, Talja M, Uutela A.
    Diabetes Care; 2007 Oct; 30(10):2465-70. PubMed ID: 17586741
    [Abstract] [Full Text] [Related]

  • 12. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.
    Hu G, Lindström J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J.
    Arch Intern Med; 2004 Apr 26; 164(8):892-6. PubMed ID: 15111376
    [Abstract] [Full Text] [Related]

  • 13. The ProActive trial protocol - a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766].
    Williams K, Prevost AT, Griffin S, Hardeman W, Hollingworth W, Spiegelhalter D, Sutton S, Ekelund U, Wareham N, Kinmonth AL.
    BMC Public Health; 2004 Oct 18; 4():48. PubMed ID: 15491494
    [Abstract] [Full Text] [Related]

  • 14. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.
    Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study (DPS) Group.
    Diabetes Care; 2008 May 18; 31(5):857-62. PubMed ID: 18252900
    [Abstract] [Full Text] [Related]

  • 15. The reporting of previous lifestyle counseling by persons at high risk of Type 2 diabetes.
    Salmela SM, Vähäsarja K, Villberg J, Vanhala M, Saaristo T, Lindström J, Oksa H, Korpi-Hyövälti E, Niskanen L, Keinänen-Kiukaanniemi S, Poskiparta M.
    Patient Educ Couns; 2012 May 18; 87(2):178-85. PubMed ID: 21943790
    [Abstract] [Full Text] [Related]

  • 16. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C, Temelkova-Kurktschiev T, Schaper F, Fücker K, Hanefeld M.
    Dtsch Med Wochenschr; 1999 Sep 17; 124(37):1057-61. PubMed ID: 10520305
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J, Lindström J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Brückner A, Peltonen M, Qiao Q, Chiasson JL.
    Diabetes Res Clin Pract; 2010 Feb 17; 87(2):267-74. PubMed ID: 20022651
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jöckel KH, Wasem J, Moebus S.
    Exp Clin Endocrinol Diabetes; 2008 Jan 17; 116(1):18-25. PubMed ID: 17926235
    [Abstract] [Full Text] [Related]

  • 19. Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project.
    Rautio N, Jokelainen J, Korpi-Hyövälti E, Oksa H, Saaristo T, Peltonen M, Moilanen L, Vanhala M, Uusitupa M, Tuomilehto J, Keinänen-Kiukaanniemi S.
    J Womens Health (Larchmt); 2014 Jun 17; 23(6):506-12. PubMed ID: 24787505
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle modification improves risk factors in type 2 diabetes relatives.
    Brekke HK, Lenner RA, Taskinen MR, Månsson JE, Funahashi T, Matsuzawa Y, Jansson PA.
    Diabetes Res Clin Pract; 2005 Apr 17; 68(1):18-28. PubMed ID: 15811562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.